<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Abou Alaiwa MH</submitter><funding>HHS | National Institutes of Health (NIH)</funding><funding>Howard Hughes Medical Institute</funding><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>Roy J Carver Charitable Trust</funding><funding>Cystic Fibrosis Foundation (CFF)</funding><pagination>18703-8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4284593</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>111(52)</volume><pubmed_abstract>The pulmonary airways are continuously exposed to bacteria. As a first line of defense against infection, the airway surface liquid (ASL) contains a complex mixture of antimicrobial factors that kill inhaled and aspirated bacteria. The composition of ASL is critical for antimicrobial effectiveness. For example, in cystic fibrosis an abnormally acidic ASL inhibits antimicrobial activity. Here, we tested the effect of pH on the activity of an ASL defensin, human β-defensin-3 (hBD-3), and the cathelicidin-related peptide, LL-37. We found that reducing pH from 8.0 to 6.8 reduced the ability of both peptides to kill Staphylococcus aureus. An acidic pH also attenuated LL-37 killing of Pseudomonas aeruginosa. In addition, we discovered synergism between hBD-3 and LL-37 in killing S. aureus. LL-37</pubmed_abstract><journal>Proceedings of the National Academy of Sciences of the United States of America</journal><pubmed_title>pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37.</pubmed_title><pmcid>PMC4284593</pmcid><funding_grant_id>IOWA</funding_grant_id><funding_grant_id>HL091842</funding_grant_id><funding_grant_id>P30 DK054759</funding_grant_id><funding_grant_id>P01 HL091842</funding_grant_id><funding_grant_id>K99 HL119560</funding_grant_id><funding_grant_id>CF0086552</funding_grant_id><funding_grant_id>P01 HL051670</funding_grant_id><funding_grant_id>HL51670</funding_grant_id><pubmed_authors>Abou Alaiwa MH</pubmed_authors><pubmed_authors>Welsh MJ</pubmed_authors><pubmed_authors>Sheets KA</pubmed_authors><pubmed_authors>Zabner J</pubmed_authors><pubmed_authors>Reznikov LR</pubmed_authors><pubmed_authors>Horswill AR</pubmed_authors><pubmed_authors>Gansemer ND</pubmed_authors><pubmed_authors>Stoltz DA</pubmed_authors></additional><is_claimable>false</is_claimable><name>pH modulates the activity and synergism of the airway surface liquid antimicrobials β-defensin-3 and LL-37.</name><description>The pulmonary airways are continuously exposed to bacteria. As a first line of defense against infection, the airway surface liquid (ASL) contains a complex mixture of antimicrobial factors that kill inhaled and aspirated bacteria. The composition of ASL is critical for antimicrobial effectiveness. For example, in cystic fibrosis an abnormally acidic ASL inhibits antimicrobial activity. Here, we tested the effect of pH on the activity of an ASL defensin, human β-defensin-3 (hBD-3), and the cathelicidin-related peptide, LL-37. We found that reducing pH from 8.0 to 6.8 reduced the ability of both peptides to kill Staphylococcus aureus. An acidic pH also attenuated LL-37 killing of Pseudomonas aeruginosa. In addition, we discovered synergism between hBD-3 and LL-37 in killing S. aureus. LL-37</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Dec</publication><modification>2025-04-04T22:04:12.137Z</modification><creation>2019-03-27T01:42:46Z</creation></dates><accession>S-EPMC4284593</accession><cross_references><pubmed>25512526</pubmed><doi>10.1073/pnas.1422091112</doi></cross_references></HashMap>